Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak.
- Resource Type
- Article
- Source
- Viruses (1999-4915); Jul2022, Vol. 14 Issue 7, pN.PAG-N.PAG, 12p
- Subject
COVID-19 pandemic MUSCULOSKELETAL system diseases COVID-19 IMMUNOCOMPROMISED patients IMMUNOSUPPRESSIVE agents ANTIVIRAL agents - Language
- ISSN
- 19994915